Intuitive Surgical Inc

Find Ratings Reports
ISRG : NASDAQ : Health Care
$1045.47 -0.82 | -0.08%
Today's Range: 1040.63 - 1053.0
Avg. Daily Volume: 332500.0
09/19/17 - 4:00 PM ET

Financial Analysis

INTUITIVE SURGICAL INC's gross profit margin for the second quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. INTUITIVE SURGICAL INC is extremely liquid. Currently, the Quick Ratio is 3.90 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

During the same period, stockholders' equity ("net worth") has decreased by 12.72% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)756.2670.1
EBITDA ($mil)0.00.0
EBIT ($mil)257.5249.8
Net Income ($mil)221.5184.5

Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)1823.42183.8
Total Assets ($mil)5250.85780.8
Total Debt ($mil)0.00.0
Equity ($mil)4522.35181.5

Profitability Q2 FY17 Q2 FY16
Gross Profit Margin69.8170.27
EBITDA Margin0.00.0
Operating Margin34.0537.28
Sales Turnover0.550.44
Return on Assets15.5411.73
Return on Equity18.0513.08
Debt Q2 FY17 Q2 FY16
Current Ratio4.415.78
Interest Expense0.00.0
Interest Coverage0.00.0

Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)37.138.5
Div / share0.00.0
Book value / share121.89134.58
Institutional Own % n/a n/a
Avg Daily Volume337873.0321022.0


BUY. This stock's P/E ratio indicates a premium compared to an average of 48.70 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 24.88. For additional comparison, its price-to-book ratio of 8.54 indicates a significant premium versus the S&P 500 average of 3.10 and a significant premium versus the industry average of 4.90. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, INTUITIVE SURGICAL INC proves to trade at a premium to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ISRG 49.83 Peers 48.70   ISRG 38.08 Peers 37.09

Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.

ISRG is trading at a valuation on par with its peers.


Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ISRG is trading at a valuation on par to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
ISRG 37.41 Peers 33.41   ISRG 1.87 Peers 1.03

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

ISRG is trading at a significant premium to its peers.


Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ISRG trades at a significant premium to its peers.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ISRG 8.54 Peers 4.90   ISRG 18.36 Peers 47.56

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ISRG is trading at a significant premium to its peers.


Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ISRG is expected to significantly trail its peers on the basis of its earnings growth rate.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ISRG 13.45 Peers 5.32   ISRG 13.41 Peers 15.38

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ISRG is trading at a significant premium to its industry.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ISRG trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades